Frank M. Torti, an officer of Roivant Sciences Ltd., filed a Form 144 notice of proposed sale of securities on November 10, 2026, covering 1,234,964 common shares with an aggregate market value of $50,732,321.12.
Key Highlights
- Seller: Frank M. Torti, identified in the filing as an officer of Roivant Sciences Ltd.
- Shares proposed for sale: 1,234,964 common shares, with an aggregate market value of $50,732,321.12 as stated in the filing.
- Source of securities: Performance Stock Units acquired from the issuer on November 10, 2026, with payment described as "Services Rendered."
- Approximate date of sale: November 10, 2026, through Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.
- Total shares outstanding: 724,561,460 common shares, according to the filing.
- Prior sales: The filing reports nothing to disclose for securities sold during the past 3 months.
Roivant Sciences Officer Files Form 144 for Proposed Common Stock Sale
According to the Form 144 notice filed with the U.S. Securities and Exchange Commission on November 10, 2026, Frank M. Torti, an officer of Roivant Sciences Ltd. (NASDAQ:ROIV), intends to sell 1,234,964 shares of common stock. The filing states the aggregate market value of the proposed sale is $50,732,321.12. The shares are proposed to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.
The filing discloses that the 1,234,964 shares were acquired on November 10, 2026, through Performance Stock Units granted by the issuer, with the nature of payment listed as "Services Rendered." The filing indicates Roivant Sciences Ltd. is the person from whom the securities were acquired, and the acquisition is not characterized as a gift. The total number of common shares outstanding at the time of the filing is reported as 724,561,460.
In the remarks and signature section, the filing states that Torti, by signing the notice, represents that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." The filing notes no securities were sold by Torti during the past three months.
What Was Disclosed
Roivant Sciences Ltd. officer Frank M. Torti filed a Form 144 notice on November 10, 2026, proposing to sell 1,234,964 common shares valued at $50,732,321.12 in aggregate, acquired via Performance Stock Units from the issuer on the same date.



Please wait processing your request...